BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Tectonic Therapeutic Inc. (TECX)

1 post
CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022

Biotech NewsTectonic Therapeutic Reports Strong Q3 2024 Financial Results, $159.1M Cash Reserves

  • BioTech Health X
  • December 27, 2024
Tectonic Therapeutic Inc. (TECX) is a cutting-edge biotechnology company dedicated to pioneering advancements in the discovery and development…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Lan Su, COO of Lakeside Holding, Shares His Vision and Strategies for Charting New Horizons
  • Voyager Therapeutics (VYGR) Reports $24.6M in Q3 2024 Collaboration Revenues
  • aTyr Pharma (ATYR) Raises $19.4 Million to Support Drug Development and Clinical Trials
  • Aquestive Therapeutics (AQST) Reports Strong Q3 2024 Financial Results with 4% Revenue Growth
  • The Next Big Player in Immuno-Oncology: iTeos Therapeutics (ITOS)
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • January 27, 2025
    Lan Su, COO of Lakeside Holding, Shares His Vision and Strategies for Charting New Horizons
    • January 19, 2025
    Voyager Therapeutics (VYGR) Reports $24.6M in Q3 2024 Collaboration Revenues
    • January 19, 2025
    aTyr Pharma (ATYR) Raises $19.4 Million to Support Drug Development and Clinical Trials
    • January 19, 2025
    Aquestive Therapeutics (AQST) Reports Strong Q3 2024 Financial Results with 4% Revenue Growth
    • January 19, 2025
    The Next Big Player in Immuno-Oncology: iTeos Therapeutics (ITOS)
Recent Posts
  • Protagonist Therapeutics (PTGX)Exceeds Revenue Estimates in Q3 2024
    • January 16, 2025
  • Madrigal Pharmaceuticals (MDGL): A Financial Powerhouse With $1.0 Billion Cash Position in 2024
    • January 16, 2025
  • Kamada (KMDA) Reports Strong Q3 2024 Financial Results with $41.7M in Revenue
    • January 14, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (122)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top